title: Gene patents and capital investment. The consequences of the revocation of Myriad's patents on the BRCA genes on venture capital investment in the life sciences.
authors.forename: Howard
authors.initials: H
authors.lastname: Wolinsky
mesh_terms: D035843:Biomedical Research / Q000191:economics* / Q000331:legislation & jurisprudence; D016520:Entrepreneurship / Q000191:economics* / Q000331:legislation & jurisprudence; D005060:Europe; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006801:Humans; D007449:Investments / Q000191:economics* / Q000331:legislation & jurisprudence; D010330:Patents as Topic; D014481:United States